Jacques Lebreton
6Patents
2h-index
20Co-inventors
51Inventor score
Filing activity: Apr 25, 1994 → Nov 22, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5602240A | Backbone modified oligonucleotide analogs | Chemistry; Metallurgy | 921 | Expired |
| US6066447A | Modified oligonucleotides | Human Necessities | 6 | Expired |
| US8361993B2 | Hydroxy-bisphosphonic acid derivatives as vector targeting bone tissue | Chemistry; Metallurgy | 1 | Active |
| US11795144B2 | Inhibitors of RAC1 and uses thereof for treating cancers | Chemistry; Metallurgy | 0 | Active |
| US11607419B2 | Inhibitors of RAC1 and uses thereof for inducing bronchodilatation | Chemistry; Metallurgy | 0 | Active |
| US12233041B2 | Disulfonate stilbenes for use in the treatment of proliferative diseases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.